[1]黄康勤.基于网络药理学预测穿心莲内酯抗呼吸道感染的分子作用机制[J].西部中医药,2022,35(03):33-39.[doi:10.12174/j.issn.2096-9600.2022.03.08]
 HUANG Kangqin.Molecular Mechanism of Andrographolide against Respiratory Tract Infection Predicted by Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(03):33-39.[doi:10.12174/j.issn.2096-9600.2022.03.08]
点击复制

基于网络药理学预测穿心莲内酯抗呼吸道感染的分子作用机制
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年03期
页码:
33-39
栏目:
出版日期:
2022-03-15

文章信息/Info

Title:
Molecular Mechanism of Andrographolide against Respiratory Tract Infection Predicted by Network Pharmacology
作者:
黄康勤
广西河池大化县人民医院,广西 河池 530800
Author(s):
HUANG Kangqin
Dahua County People’s Hospital, Hechi 530800, China
关键词:
呼吸道感染网络药理学分子对接穿心莲内酯
Keywords:
respiratory tract infectionnetwork pharmacologymolecular dockingandrographolide
分类号:
R254
DOI:
10.12174/j.issn.2096-9600.2022.03.08
文献标志码:
A
摘要:
目的基于网络药理学系统探究穿心莲内酯抗呼吸道感染的分子作用机制。 方法采用网络药理学方法从Pubchem查找穿心莲内酯的相关信息,在PubMed、DrugBank、Swiss Target Prediction和BATMAN数据库查找穿心莲内酯的作用靶标,再从CTD数据库、Genecards和DiGSEE数据库查寻关于呼吸道感染的相关靶标,通过将穿心莲内酯的作用靶标与呼吸道感染的相关靶标进行交集得到重叠靶标,再用生物信息学方法分析重叠靶标,最后用分子对接方法反向验证预测的靶标与穿心莲内酯的结合性。 结果共收集到穿心莲内酯114个作用靶标,其中35个潜在作用靶标与呼吸道感染发病机制相关,这些潜在作用靶标参与多种生物学过程,富集出93条信号通路;分子对接结果显示穿心莲内酯与作用靶点有较好的结合性,且该预测具有一定准确性。 结论穿心莲内酯通过与多种受体蛋白结合多靶点、多途径地干预呼吸道感染的发生发展。
Abstract:
ObjectiveTo systematically explore molecular mechanism of andrographolide against respiratory tract infection (RTI). MethodsThe relevant information of andrographolide was searched from Pubchem by using network pharmacology method, the action targets of andrographolide were sought from PubMed, DrugBank, Swiss Target Prediction and BATMAN database, the relevant targets of RTI were surveyed from CTD, Genecards and DIGSEE databases, the overlapping targets were obtained by intersecting the action targets of andrographolide and the related targets of RTI, and they were analyzed by bioinformatics method, finally, the binding between the predicted targets and andrographolide was inversely verified by molecular docking method. ResultsA total of 114 action targets of andrographolide have been collected, among them, 35 potential action targets are related to the mechanism of RTI, these potential action targets participate in a variety of biological processes, and 93 signaling pathways are enriched; molecular docking results indicates that andrographolide has good binding with the action targets, and the prediction has certain accuracy. ConclusionAndrographolide could intervene the incidence and development of RTI through binding with a variety of receptor proteins via many targets and channels.

相似文献/References:

[1]李永鸿.玉屏风散加味治疗小儿反复呼吸道感染43例[J].西部中医药,2013,26(06):60.
 LI Yonghong.Modified YuPingFeng San in Treating 43 Cases of Recurrent Respiratory Tract Infection in Children[J].Western Journal of Traditional Chinese Medicine,2013,26(03):60.
[2]沈玉鹏,任耀全,李冬梅,等.穴位贴敷联合中药辨证治疗对反复呼吸道感染患儿免疫及微量元素的影响[J].西部中医药,2016,29(05):96.
 SHEN Yupeng,REN Yaoquan,LI Dongmei,et al.The Influence of Acupoint Application Combined with Syndrome Differentiation and Herbs on the Immunity and Trace Elements of the Children with Recurrent Respiratory Tract Infection[J].Western Journal of Traditional Chinese Medicine,2016,29(03):96.
[3]田琳,毕胜男,陈梦竹,等.基于网络药理学探索血府逐瘀汤治疗非小细胞肺癌的作用机制[J].西部中医药,2022,35(01):21.[doi:10.12174/j.issn.2096-9600.2022.01.05]
 TIAN Lin,BI Shengnan,CHEN Mengzhu,et al.Research on the Mechanism of Xuefu Zhuyu Decoction in the Treatment of NSCLC Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(03):21.[doi:10.12174/j.issn.2096-9600.2022.01.05]
[4]吴春凤,黄艳霞,郑景辉.基于网络药理学分析荆芥—防风药对的分子作用机制[J].西部中医药,2022,35(02):74.[doi:10.12174/j.issn.2096-9600.2022.02.18]
 WU Chunfeng,HUANG Yanxia,ZHENG Jinghui.Molecular Mechanism of Couplet Medicinals Jingjie‐Fangfeng Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(03):74.[doi:10.12174/j.issn.2096-9600.2022.02.18]
[5]陶鑫,薛中峰,覃骊兰.基于网络药理学的过敏煎治疗过敏性哮喘分子机制研究[J].西部中医药,2022,35(03):27.[doi:10.12174/j.issn.2096-9600.2022.03.07]
 TAO Xin,XUE Zhongfeng,QIN Lilan.Study on the Molecular Mechanism of Guomin Jian in the Treatment of Allergic Asthma Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(03):27.[doi:10.12174/j.issn.2096-9600.2022.03.07]
[6]石威,张俊忠,解鹏超,等.基于网络药理学和分子对接探析淫羊藿-牛膝药对治疗股骨头坏死的作用机制[J].西部中医药,2022,35(04):35.[doi:10.12174/j.issn.2096-9600.2022.04.09]
 SHI Wei,ZHANG Junzhong,XIE Pengchao,et al.Study on the Mechanism of Yinyanghuo-Niuxi Drug Pair in Treating Femoral Head Necrosis Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2022,35(03):35.[doi:10.12174/j.issn.2096-9600.2022.04.09]
[7]刘卓超,黄小靖,曾志聪.黄连生物碱改善心力衰竭的网络药理学机制研究[J].西部中医药,2022,35(04):42.[doi:10.12174/j.issn.2096-9600.2022.04.10]
 LIU Zhuochao,HUANG Xiaojing,ZENG Zhicong.Study on the Mechanism of Coptis Alkaloid in the Treatment of Heart Failure Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(03):42.[doi:10.12174/j.issn.2096-9600.2022.04.10]
[8]张维芯,周青,戴国梁,等.基于SARS-CoV-2关键蛋白ACE2探索“葛根-柴胡”治疗COVID-19的潜在机制[J].西部中医药,2022,35(05):1.[doi:10.12174/j.issn.2096-9600.2022.05.01]
 ZHANG Weixin,ZHOU Qing,DAI Guoliang,et al.The Potential Mechanism of “Gegen-Chaihu” in the Treatment of COVID-19 Based on SARS-CoV-2 Target Protein ACE2[J].Western Journal of Traditional Chinese Medicine,2022,35(03):1.[doi:10.12174/j.issn.2096-9600.2022.05.01]
[9]林鑫,刘阳,陈林伟,等.基于网络药理学探讨气血双补方抗慢性心力衰竭的作用机制[J].西部中医药,2022,35(06):29.[doi:10.12174/j.issn.2096-9600.2022.06.08]
 LIN Xin,LIU Yang,CHEN Linwei,et al.Study on the Mechanism of Qixue Shuangbu Prescription in Treating Chronic Heart Failure Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(03):29.[doi:10.12174/j.issn.2096-9600.2022.06.08]
[10]潘威.基于网络药理学探讨大黄治疗溃疡性结肠炎的机制[J].西部中医药,2022,35(06):80.[doi:10.12174/j.issn.2096-9600.2022.06.21]
 PAN Wei.The Mechanism of Dahuang in Treating Ulcerative Colitis Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(03):80.[doi:10.12174/j.issn.2096-9600.2022.06.21]

备注/Memo

备注/Memo:
黄康勤(1968—),男,副主任药师。研究方向:药学。
更新日期/Last Update: 2022-06-24